.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Antiretroviral therapy has transformed HIV into a manageable condition. However, some patients remain HIV immunological non-responders who cannot adequately restore their CD4+ T-cell counts. These individuals face increased risks of morbidity and mortality because their immune systems stay compromised. Scientists recently analyzed multi-omics data from the 2000HIV study to understand this phenomenon. Their findings highlight the critical role of the Src kinase-associated phosphoprotein 1, or SKAP1, in immune reconstitution.
The study compared plasma protein levels between responders and non-responders. Significantly, the research team found that HIV immunological non-responders have much lower SKAP1 concentrations. These plasma levels directly reflect the intracellular levels within CD4+ T-cells. Because SKAP1 facilitates T-cell proliferation and migration, its depletion poses a significant hurdle. Consequently, the body cannot effectively rebuild its immune defense.
Moreover, DNA methylation analysis provided a biological reason for this protein deficiency. The team discovered significant hypermethylation at the SKAP1 promoter region. This epigenetic change essentially silences the gene, leading to reduced protein production. Furthermore, three specific single-nucleotide polymorphisms close to the gene appeared to associate with poor immune responses. Preliminary data also suggest that persistent infections like CMV might further suppress SKAP1 expression.
These insights offer a potential roadmap for new treatment strategies. Addressing the hypermethylation of the SKAP1 promoter might help revive T-cell activity. Additionally, monitoring SKAP1 levels could serve as a biomarker for clinical risk. Clinicians should remain aware of these biological barriers when managing patients with persistently low CD4 counts despite viral control.
These are individuals living with HIV who achieve viral suppression through antiretroviral therapy but fail to restore their CD4+ T-cell counts to healthy levels, typically remaining below 350 or 500 cells/mm³.
SKAP1 is an adaptor protein essential for T-cell proliferation and migration. Low levels of this protein, often caused by DNA hypermethylation, hinder the body's ability to regenerate the CD4+ T-cell pool.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study reveals that low SKAP1 protein and DNA hypermethylation contribute to inadequate CD4+ T-cell restoration in HIV immunological non-responders....
4 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
